Addex Therapeutics is pioneering discovery and development of an emerging class of oral small molecule drugs, called allosteric modulators, which can be selective for their intended target and confer significant therapeutic advantages over conventional orthosteric small molecule or biological drugs.

Location
Facts & figures
  • Type of organization
    Public company
  • Year of foundation
    2002
  • Number of employees in Switzerland
    10-19
Key business